Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rituximab (rituxan) (1 trial)
Eye Diseases (Phase 2)
Graves Ophthalmopathy (Phase 2)
Trials (1 total)
Trial APIs (1 total)